Vitamin D mitigates diabetes-associated metabolic and cognitive dysfunction by modulating gut microbiota and colonic cannabinoid receptor 1.

Hussein, Hebatallah M; Elyamany, Mohammed F; Rashed, Laila A; Sallam, Nada A

Hussein, Hebatallah M; Elyamany, Mohammed F; Rashed, Laila A; Sallam, Nada A.

Afiliação

Hussein HM; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Kasr Al-Aini street, Cairo 11562, Egypt.
Elyamany MF; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Kasr Al-Aini street, Cairo 11562, Egypt.
Rashed LA; Department of Biochemistry and Molecular Biology, Faculty of Medicine, Cairo University, Egypt.
Sallam NA; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Kasr Al-Aini street, Cairo 11562, Egypt. Electronic address: nada.sallam@pharma.cu.edu.eg.

Eur J Pharm Sci ; 170: 106105, 2022 Mar 01.

Article em En | MEDLINE | ID: mdl-34942358

Assuntos

Disfunção Cognitiva; Diabetes Mellitus Tipo 2; Microbioma Gastrointestinal; Receptor CB1 de Canabinoide; Animais; Dieta Hiperlipídica; Camundongos; Camundongos Endogâmicos C57BL; Doenças Neuroinflamatórias; Ratos; Receptores de Canabinoides; Vitamina D

Palavras-chave

CB1R; Cognitive function; Diabetes; Gut microbiota; Obesity; Vitamin D

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptor CB1 de Canabinoide / Diabetes Mellitus Tipo 2 / Disfunção Cognitiva / Microbioma Gastrointestinal Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals Idioma: En Revista: Eur J Pharm Sci Assunto da revista: FARMACIA / FARMACOLOGIA / QUIMICA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Egito

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google